arsenic has been researched along with Nasopharyngeal Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flemington, EK; Lasky, JA; Lin, Z; Luo, F; Sides, MD; Sosulski, ML | 1 |
| Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H; Zhou, K | 1 |
| Hu, J; Huang, X; Wang, X; Zhang, Y; Zhou, H | 1 |
3 other study(ies) available for arsenic and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Heterografts; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Treatment Outcome; Tumor Burden | 2013 |
[Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice].
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; Death-Associated Protein Kinases; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxides; Xenograft Model Antitumor Assays | 2013 |
[Effects of arsenic trioxide combined with cisplatin on the growth of human nasopharyngeal carcinoma cells and reversion of RASSF1A hympermethylation].
Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cisplatin; DNA Methylation; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Oxides; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2014 |